BDX Insider Trading

Insider Ownership Percentage: 0.36%
Insider Buying (Last 12 Months): $350,430.00
Insider Selling (Last 12 Months): $4,840,015.53

Becton, Dickinson and Company Insider Trading History Chart

This chart shows the insider buying and selling history at Becton, Dickinson and Company by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$350kbought$1.04MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4M-$2M$0$2M$4MTotal Insider BuyingTotal Insider Selling

Becton, Dickinson and Company Share Price & Price History

Current Price: $226.43
Price Change: Price Increase of +3.637 (1.63%)
As of 03/14/2025 04:59 PM ET

This chart shows the closing price history over time for BDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$226.43Closing price on 03/15/25:

SEC Filings (Institutional Ownership Changes) for Becton, Dickinson and Company (NYSE:BDX)

86.97% of Becton, Dickinson and Company stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BDX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$5.24Bbought$2.97BsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4B-$2B$0$2B$4BTotal InflowsTotal Outflows
Becton, Dickinson and Company logo
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Read More on Becton, Dickinson and Company

Today's Range

Now: $226.43
Low: $221.98
High: $226.47

50 Day Range

MA: $232.78
Low: $222.65
High: $249.75

52 Week Range

Now: $226.43
Low: $218.75
High: $251.99

Volume

1,157,171 shs

Average Volume

1,514,823 shs

Market Capitalization

$65.02 billion

P/E Ratio

37.61

Dividend Yield

1.81%

Beta

0.35

Who are the company insiders with the largest holdings of Becton, Dickinson and Company?

Becton, Dickinson and Company's top insider shareholders include:
  1. Bertram L Scott (Director)
  2. Roland Goette (EVP)
  3. Claire Fraser (Director)
  4. Shana Carol Neal (EVP)
  5. Jeffrey William Henderson (Director)
  6. Richard Byrd (EVP)
  7. Michael David Garrison (EVP)
  8. David Shan (EVP)
  9. David Hickey (EVP)
  10. Thomas J Spoerel (SVP)
Learn More about top insider investors at Becton, Dickinson and Company.

Who are the major institutional investors of Becton, Dickinson and Company?

Becton, Dickinson and Company's top institutional shareholders include:
  1. Vanguard Group Inc. — 9.22%
  2. Price T Rowe Associates Inc. MD — 4.26%
  3. T. Rowe Price Investment Management Inc. — 4.18%
  4. Geode Capital Management LLC — 2.19%
  5. Massachusetts Financial Services Co. MA — 2.13%
  6. First Eagle Investment Management LLC — 1.53%
Learn More about top institutional investors of Becton, Dickinson and Company stock.

Which major investors are selling Becton, Dickinson and Company stock?

Within the previous quarter, BDX stock was sold by these institutional investors:
  1. Bank of New York Mellon Corp
  2. Price T Rowe Associates Inc. MD
  3. Ameriprise Financial Inc.
  4. Ontario Teachers Pension Plan Board
  5. Mackenzie Financial Corp
  6. Principal Financial Group Inc.
  7. Franklin Resources Inc.
  8. Legal & General Group Plc
In the last year, company insiders that have sold Becton, Dickinson and Company company stock include:
  1. Bertram L Scott (Director)
  2. Roland Goette (EVP)
  3. Claire Fraser (Director)
  4. Shana Carol Neal (EVP)
  5. Jeffrey William Henderson (Director)
  6. Richard Byrd (EVP)
  7. Michael David Garrison (EVP)
Learn More investors selling Becton, Dickinson and Company stock.

Which major investors are buying Becton, Dickinson and Company stock?

During the last quarter, BDX stock was purchased by institutional investors including:
  1. Norges Bank
  2. T. Rowe Price Investment Management Inc.
  3. Kovitz Investment Group Partners LLC
  4. First Eagle Investment Management LLC
  5. Massachusetts Financial Services Co. MA
  6. Raymond James Financial Inc.
  7. Nordea Investment Management AB
  8. Citadel Advisors LLC